Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.47 Insider Own0.10% Shs Outstand111.24M Perf Week-3.49%
Market Cap2.03B Forward P/E- EPS next Y-1.30 Insider Trans- Shs Float110.24M Perf Month-32.76%
Income-147.00M PEG- EPS next Q-0.40 Inst Own90.90% Short Float13.05% Perf Quarter-48.22%
Sales0.09M P/S22042.45 EPS this Y-115.90% Inst Trans-0.09% Short Ratio8.52 Perf Half Y-52.09%
Book/sh2.26 P/B8.07 EPS next Y17.70% ROA-51.20% Target Price48.20 Perf Year-45.53%
Cash/sh2.16 P/C8.43 EPS next 5Y20.00% ROE-54.60% 52W Range16.64 - 51.99 Perf YTD-48.86%
Dividend- P/FCF- EPS past 5Y4.60% ROI-30.10% 52W High-64.94% Beta3.41
Dividend %- Quick Ratio13.70 Sales past 5Y-56.50% Gross Margin- 52W Low9.56% ATR2.24
Employees151 Current Ratio13.70 Sales Q/Q160.00% Oper. Margin- RSI (14)29.65 Volatility10.68% 11.26%
OptionableYes Debt/Eq0.00 EPS Q/Q-56.00% Profit Margin- Rel Volume0.93 Prev Close18.48
ShortableYes LT Debt/Eq0.00 EarningsFeb 25 AMC Payout- Avg Volume1.69M Price18.23
Recom1.80 SMA20-16.61% SMA50-37.86% SMA200-50.46% Volume1,567,600 Change-1.35%
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Apr-11-13Reiterated Needham Buy $9 → $16
Apr-11-13Reiterated MLV & Co Buy $12.50 → $18
Apr-11-13Reiterated Ladenburg Thalmann Buy $9 → $15
Mar-13-13Reiterated Ladenburg Thalmann Buy $8 → $9
Nov-28-12Reiterated MLV & Co Buy $4.50 → $8.50
Nov-27-12Upgrade Needham Hold → Buy $9
Nov-27-12Reiterated Ladenburg Thalmann Buy $8
Feb-08-16 10:32AM  Why Are Analysts So Bullish On This Tumbling Biotech Company? -8.26%
07:12AM  Coverage initiated on ACADIA Pharmaceuticals by BofA/Merrill
Feb-03-16 09:00AM  ACADIA Pharmaceuticals to Present at the LEERINK Partners 5th Annual Global Healthcare Conference on February 10, 2016 Business Wire
08:00AM  Biotechnology Stocks Technical Snapshot -- Geron, ACADIA Pharma, Alexion Pharma, and Illumina Accesswire
Feb-01-16 08:55AM  Acadia Pharmaceuticals Are Spiking
Jan-29-16 04:19PM  ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID (Pimavanserin) for the Treatment of Parkinsons Disease Psychosis at noodls
04:05PM  ACADIA Pharmaceuticals Announces FDA Advisory Committee Meeting to Review NUPLAZID (Pimavanserin) for the Treatment of Parkinsons Disease Psychosis Business Wire
Jan-25-16 09:27AM  ACADIA Pharmaceuticals Appoints James (Randy) R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer at noodls
09:00AM  ACADIA Pharmaceuticals Appoints James (Randy) R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer Business Wire
Jan-22-16 08:16AM  Analysts' Actions -- Alaska Air, Avon, Bristol-Myers, Goldman Sachs and More +8.21%
Jan-13-16 09:02AM  5 Stocks Insiders Love Right Now at TheStreet -14.46%
Jan-12-16 04:31PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-11-16 09:00AM  ACADIA Pharmaceuticals Appoints Jim Daly to Board of Directors Business Wire
Jan-07-16 05:01PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial St
11:32AM  Why Shares of ACADIA Pharmaceuticals Inc. Are Falling Off a Cliff at Motley Fool
09:00AM  ACADIA Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference on January 12, 2016 Business Wire
Jan-06-16 09:35PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire -15.15%
Jan-05-16 04:17PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
04:05PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire
Dec-30-15 08:01AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 30, 2015
Dec-21-15 12:20PM  Cerecor, fresh off an IPO, names CEO to replace Paterson at bizjournals.com
Dec-17-15 08:38AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 17, 2015
Dec-15-15 05:13PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
09:00AM  ACADIA Pharmaceuticals Appoints Julian C. Baker to Board of Directors Business Wire
Dec-09-15 10:17AM  Top 5 Healthcare Bets of World-Class Baker Bros. Advisors at Insider Monkey
Dec-08-15 01:17PM  ACADIA PHARMACEUTICALS INC Financials
Dec-04-15 12:46PM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : December 4, 2015
Dec-02-15 05:50AM  ACADIA Pharmaceuticals Inc. (ACAD): Are Hedge Funds Right About This Stock? at Insider Monkey
Nov-30-15 05:09PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
09:01AM  ACADIA Pharmaceuticals Appoints Srdjan (Serge) Stankovic, M.D., M.S.P.H., as Executive Vice President, Head of Research and Development Business Wire
09:00AM  ACADIA Pharmaceuticals Appoints Edmund P. Harrigan, M.D., to Board of Directors Business Wire
Nov-27-15 09:09PM  We Dig Into the Smart Money Sentiment Towards Nice Systems Ltd (ADR) (NICE) at Insider Monkey
Nov-24-15 06:39PM  Do Hedge Funds Love Dolby Laboratories, Inc. (DLB)? at Insider Monkey
Nov-10-15 11:32AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : November 10, 2015
08:06AM  Dyax and Acadia Drove XBIs Mid-Cap Space
Nov-09-15 08:07AM  Myriad Genetics: Top Performer in the Biotechnology Subgroup
Nov-06-15 05:16PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -11.53%
Nov-05-15 05:19PM  Acadia reports 3Q loss
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:19PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  ACADIA Pharmaceuticals Reports Third Quarter 2015 Financial Results Business Wire
07:07AM  Q3 2015 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
Nov-04-15 09:00AM  ACADIA Pharmaceuticals to Present at the 24th Annual Credit Suisse Healthcare Conference on November 10, 2015 Business Wire
Nov-02-15 05:04PM  Axovant to start pair of dementia drugs trials at Financial Times +15.39%
03:24PM  Why Acadia Pharmaceuticals Is Up Today at Motley Fool
02:57PM  Why Are These Four Stocks Making A Late Surge? at Insider Monkey
02:22PM  3 Stocks Spiking on Big Volume at TheStreet
08:00AM  ACADIA Pharmaceuticals Announces FDA Priority Review of NUPLAZID (Pimavanserin) New Drug Application for Parkinsons Disease Psychosis Business Wire
Oct-29-15 09:00AM  ACADIA Pharmaceuticals to Announce Third Quarter Financial Results on November 5, 2015 Business Wire
08:56AM  Acadia's New Drug Could Have Potential for Investors at TheStreet
Oct-09-15 12:08PM  IMMU and ACRX Outperform in the Biotech Downdraft
Oct-02-15 04:07PM  XBIs Top Ten Small-Cap Stocks Perform on Par with Large-Caps +5.78%
10:43AM  ACADIA Pharmaceuticals, Inc. Earnings Q2, 2015
Sep-30-15 01:06PM  Akorn Slumps 6.36% +8.04%
Sep-29-15 12:08PM  ENDP Trades above 100-Day Moving Average
Sep-28-15 09:07AM  Dyax Traded above Its 100-Day Moving Average -6.79%
Sep-25-15 05:53PM  5 Sell-Ranked Biotechs That Fell More Than 5% Today -7.60%
Sep-22-15 04:01PM  ACADIA Pharmaceuticals to Present at the Ladenburg Thalmann 2015 Healthcare Conference on September 29, 2015 Business Wire
Sep-21-15 08:29AM  Neurocrine and Clovis Help Pharmaceuticals to Outperform -9.79%
Sep-17-15 01:25PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : September 17, 2015
10:15AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : September 17, 2015
Sep-16-15 09:26AM  3 Healthcare Stocks That Could Add a Spark to Your Portfolio at Motley Fool
Sep-09-15 10:53AM  Biotech Stock Roundup: Biosimilar Competition for Amgen, Tetraphase Hit By Disappointing Data
Sep-03-15 04:21PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Ex
12:27PM  Why Parkinson's Disease-Focused ACADIA Pharmaceuticals is Soaring Today at Motley Fool
10:57AM  Acadia Pharmaceuticals (ACAD) Stock Climbs on Drug Application for Parkinson's Treatment at TheStreet
07:15AM  Acadia Pharmaceuticals submits new FDA for Parkinson's psychosis drug at MarketWatch
07:01AM  ACADIA Pharmaceuticals Appoints Steve Davis as Chief Executive Officer Business Wire
07:00AM  ACADIA Pharmaceuticals Submits New Drug Application for NUPLAZID for the Treatment of Parkinsons Disease Psychosis Business Wire
Sep-02-15 01:03PM  XBI Pharmaceutical Valuation Rises on Strong Small-Cap Performance +6.02%
01:02PM  Acadia, Neurocrine, Dyax, and Opko Trade Below 50-Day Moving Average
Aug-27-15 03:06PM  Why Piper Jaffray Is Upgrading Acadia Pharmaceuticals After A 25% Decline
12:06PM  Acadia Pharmaceuticals Fell 19% after Reporting 2Q15 Earnings
Aug-25-15 11:55AM  Some Pharma Stocks Trade below All Moving Averages in Early August
11:55AM  Pharmaceutical Stocks Affect the iShares NASDAQ Biotechnology ETF
11:55AM  IBB ETF Pounded by Biotech and Pharma Subgroups in Early August
09:17AM  What Are IBB and XBIs Valuations?
Aug-21-15 04:28PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Aug-14-15 09:05AM  What Were the Valuations for IBBs Pharmaceutical Sector?
08:49AM  Why ACADIA Pharmaceuticals (ACAD) Could Be Positioned for a Slump
Aug-13-15 08:52AM  Horizon Pharma Delivers Strong 2Q15 Results
Aug-11-15 08:33AM  This Undervalued Biotech Company Just Filed For FDA Approval and No One Noticed
Aug-08-15 08:10PM  10-Q for ACADIA Pharmaceuticals, Inc. at Company Spotlight
Aug-07-15 02:11PM  Why ACADIA Pharmaceuticals Inc. is Dropping Today at Motley Fool -13.31%
01:27PM  Acadia Pharma May No Longer Be A Buy Ahead Of NDA Filing
Aug-06-15 07:33PM  Acadia reports 2Q loss -5.15%
07:05PM  Edited Transcript of ACAD earnings conference call or presentation 6-Aug-15 9:00pm GMT
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:05PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:01PM  ACADIA Pharmaceuticals Reports Second Quarter 2015 Financial Results Business Wire
09:00AM  ACADIA Pharmaceuticals Announces Publication of Data from Its -015 Open Label Safety Study in Parkinsons Disease Psychosis in the Journal of the American Medical Directors Association Business Wire
07:07AM  Q2 2015 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
Aug-05-15 03:23PM  Why ACADIA Pharmaceuticals Inc Jumped 17% in July at Motley Fool
09:00AM  ACADIA Pharmaceuticals Announces Senior Management Appointments in Manufacturing, Quality, Compliance, Access and Reimbursement and Business Development Business Wire
Jul-30-15 09:00AM  ACADIA Pharmaceuticals to Announce Second Quarter Financial Results on August 6, 2015 Business Wire
Jul-13-15 12:28PM  Notable option activity in equities
Jun-26-15 03:31AM  Edited Transcript of ACAD presentation 24-Jun-15 3:00pm GMT
Jun-19-15 04:43PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jun-17-15 09:00AM  ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 24, 2015 Business Wire
Jun-16-15 09:00AM  ACADIA Pharmaceuticals Presents Integrated Data from Its Phase III Program with NUPLAZID (Pimavanserin) for Parkinsons Disease Psychosis at the 19th International Congress of Parkinsons Disease and Movement Disorders Business Wire
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis; is in Phase II study for Alzheimer's disease psychosis; and has completed Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
14159, L.P.DirectorJan 07Buy29.002,586,20674,999,97420,278,008Jan 08 06:07 PM
Iversen Leslie LDirectorNov 11Option Exercise7.8630,000235,66966,127Nov 13 05:45 PM
Iversen Leslie LDirectorNov 11Sale36.0130,0001,080,32736,127Nov 13 05:45 PM
Iversen Leslie LDirectorAug 19Option Exercise11.008,50093,50036,127Aug 21 04:26 PM
Iversen Leslie LDirectorAug 19Option Exercise11.008,50093,50036,127Aug 21 04:26 PM
KAPLAN LESTER J PH DDirectorAug 11Option Exercise11.008,50093,50017,000Aug 13 05:10 PM
Iversen Leslie LDirectorJun 01Option Exercise8.8514,127125,02427,627Jun 03 04:04 PM
Hacksell UliCEOFeb 17Option Exercise1.5530,00046,50030,000Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Option Exercise4.9019,84797,20128,347Feb 19 06:00 PM
Hacksell UliCEOFeb 17Sale34.3030,0001,028,868115,549Feb 19 05:58 PM
Rasmussen TorstenDirectorFeb 17Sale35.0519,847695,5448,500Feb 19 06:00 PM